Why RPI to CPI switch throws up challenges for bulk annuities
While moving to CPI indexation can significantly reduce scheme liabilities, it can make buy-ins and buyouts more expensive. Kristian Brunt-Seymour finds pricing has slightly improved but still has a long way to go
At a glance: A typical scheme can reduce liabilities by 10%-15% by converting from RPI to CPI Can pave the way to doing buy-in or buyout but pricing tends to be closer to RPI Events surrounding...
More on Defined Benefit
Aegon partners with HSBC to embed ESG criteria into default funds
Aegon has embedded ESG criteria across its in-house workplace default funds through a partnership with HSBC Global Asset Management.
USS: Cost of scheme is 'growing challenge' as future returns 'likely to be lower'
The Universities Superannuation Scheme (USS) trustee board has warned investment returns will be lower in the future than expected as it edges closer to concluding its 2020 valuation.
DB schemes should use 2020 crisis as a 'learning opportunity'
There are many lessons to be learned from the March 2020 market volatility and liquidity squeeze as the Covid-19 pandemic escalated, Barnett Waddingham says.
What will the real estate sector look like after Covid-19?
Retail and hotels have taken the brunt of lockdowns, while logistics and residential have fared much better. Even when Covid-19 is bought under control, the path of recovery is far from straightforward, writes Stephanie Baxter
Evonik scheme completes £544m full buy-in with L&G
The defined benefit (DB) scheme of Evonik Holdings UK has agreed a £544m full buy-in with Legal & General (L&G) Assurance Society.
